Smith Anglin Financial »

Cognition Therapeutics shares owned by Smith Anglin Financial

Quarter-by-quarter ownership of Cognition Therapeutics (CGTX) shares owned by Smith Anglin Financial from 13F filings

Historical chart of Smith Anglin Financial investment in Cognition Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cognition Therapeutics held by Smith Anglin Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cognition Therapeutics by Smith Anglin Financial

Quarter filed Position value Share count Share price at filing
2024-12-31 $8.4k 12k 0.70
2024-09-30 $5.6k 12k 0.47
2024-06-30 $20k 12k 1.66
2024-03-31 $22k 12k 1.82
2023-12-31 $22k 12k 1.85

More positions owned by Smith Anglin Financial

Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Core Div Grwth (DGRO)
American Centy Etf Tr Us Eqt Etf (AVUS)
Invesco Exchange Traded Fd T S&p Mdcp Quality (XMHQ)
Cambria Etf Tr Shshld Yield Etf (SYLD)
Cambria Etf Tr Emrg Sharehldr (EYLD)
Ishares Tr 10-20 Yr Trs Etf (TLH)
Cambria Etf Tr Cambria Fgn Shr (FYLD)
Apple (AAPL)
Ishares Tr S&p 500 Grwt Etf (IVW)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Wisdomtree Tr Cybersecurity Fd (WCBR)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for Smith Anglin Financial

Top funds holding Cognition Therapeutics

Vanguard Group
Alyeska Investment Group
Geode Capital Management
CM Management
American Financial Group
UBS Group
Sigma Planning
Kestra Advisory Services
BlackRock
Acadian Asset Management
Commonwealth Equity Services
Renaissance Technologies
Bridgeway Capital Management
State Street Corporation
Virtu Financial

View all funds holding Cognition Therapeutics